How many institutions held MNPR - Monopar Therapeutics - Common Stock, par value $0.001 per share in Q3 2024?

6 institutional investors reported MNPR - Monopar Therapeutics - Common Stock, par value $0.001 per share for Q3 2024. Use the holders table for investor-level position and value details.

Monopar Therapeutics - Common Stock, par value $0.001 per share (MNPR)

Q: What does CUSIP 61023L207 represent in this 13F holders report?

CUSIP 61023L207 is the security identifier for MNPR - Monopar Therapeutics - Common Stock, par value $0.001 per share used to aggregate holder disclosures.

CUSIP: 61023L207

Q3 2024 13F Holders as of 30 Sep 2024

Type / Class: Equity / Common Stock, par value $0.001 per share
Shares outstanding: 6,743,758
Total 13F shares: 15,707
Share change: +15,707
Total reported value: $105,865
Price per share: $6.74
Number of holders: 6
Value change: +$105,865
Number of buys: 6

Quarterly Holders Quick Answers

What is CUSIP 61023L207?
CUSIP 61023L207 identifies MNPR - Monopar Therapeutics - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q4 2024

Recent filing periods for CUSIP 61023L207:

Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024

Institutional Holders of Monopar Therapeutics - Common Stock, par value $0.001 per share (MNPR) as of Q3 2024

As of 30 Sep 2024, Monopar Therapeutics - Common Stock, par value $0.001 per share (MNPR) was held by 6 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 15,707 shares. The largest 6 holders included GEODE CAPITAL MANAGEMENT, LLC, NewEdge Advisors, LLC, UBS Group AG, WELLS FARGO & COMPANY/MN, Federation des caisses Desjardins du Quebec, and BANK OF AMERICA CORP /DE/. This page lists 6 institutional shareholders reporting positions in this security for the Q3 2024 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.